Biowaive the lower dosages forms [Design Issues]

posted by MaggieSantos – Portugal, 2014-06-16 18:54 (4395 d 09:32 ago) – Posting: # 13071
Views: 3,827

Dear All,

I would like to have your opinion on the chance to aply a biowaiver to the lower dosages of Telmisartan alone or FDC with telmisartan. (from 80 mg to 40 mg)

Since there is no pharmacokinetic linear relationship between doses and plasma concentrations, I am not quite sure if the bioequivalence study with the 80 mg telmisartan dosages (alone or as FDC) is enough to biowave the 40 mg dosages (assuming all other permisses are fulfilled).


Best Regards

MaggieSantos

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
368 visitors (0 registered, 368 guests [including 28 identified bots]).
Forum time: 04:26 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5